Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2018) 56 GP248 | DOI: 10.1530/endoabs.56.GP248

ECE2018 Guided Posters Thyroid non cancer (9 abstracts)

Thyroid function in early-treated adult PKU patients

Csaba Sumánszki 1 , Erika Kiss 2 , Erika Simon 2 , Attilla Patócs 3, & Endre Nagy 6


12nd Department of Medicine, Semmelweis University, Budapest, Hungary; 21st Department of Pediatrics, Semmelweis University, Budapest, Hungary; 3Department of Laboratory Medicine, Budapest, Hungary; 4Molecular Medicine Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary; 5‘Lendület-2013’ Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary; 6Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.


Introduction: Phenylketonuria (PKU) is a rare inherited metabolic disorder that leads to the toxic accumulation of phenylalanine (Phe) causing usually severe mental retardation and seizures. The basis of the lifelong therapy is low in natural-protein diet and Phe-free amino acid mixtures, that provide the daily necessary amino acids, vitamins and micronutrients, such as Iodine and Selenium. It is not well known, whether the adherence to the therapy can influence the thyroid function in early-treated adult PKU patients.

Method: A prospective, cross-sectional study was conducted to assess the thyroid function, ultrasound structure and Iodine status of early-treated adult PKU patients. Seventy-five PKU patients (age 18–41 years) were included in this study. Based on their blood Phe values they were divided into two groups, with the cut-off point being the upper limit of 600 μmol/l: on-diet (n=27) and loose-diet (n=48) group. Spot urine Iodine concentration (I) and Iodine/creatinine ratio (I/Cr), blood Phe, Tyr, free triiodothyronine (fT3), free thyroxine (fT4), fT3/fT4 ratio, thyroid-stimulating hormone (TSH), thyroglobulin, anti-thyroglobulin antibody, anti-thyroid peroxidase antibody were measured and thyroid ultrasound was performed. The results were compared between the two groups.

Results: None of the PKU patients have abnormal thyroid function. The prevalence of thyroid nodes seen on ultrasound was 21.3%. Blood Phe or Tyr even Phe/Tyr ratio were not associated with TSH, fT4, fT3 or fT3/fT4 ratio or with the antibodies. However, we observed a significant difference in the urine Iodine concentration and I/Cr ratio between the two groups (P<0.05, P<0.01 respectively). The loose-diet group based on the I concentration (median of 99.14 μg/l, 28.8% <50 μg/l, 51.1% <100 μg/l) could be classified as Iodine deficient subpopulation. Blood Phe correlated inverse with the I concentration and I/Cr ratio (r=−0.28, P<0.05; r=−0.37, P<0.01), while blood Tyr showed correlation with I/Cr (r=0.30, P<0.05). fT3, TSH, Thyroglobulin, thyroid antibodies and fT3/fT4 ratio showed no significant difference between the groups, however, fT4 was significantly higher in the on-diet group (P<0.05, on-diet: 14.15 pmol/l±1.9 S.D.; loose-diet: 13.23 pmol/l±1.3 S.D.).

Conclusion: The result of this study suggests that Iodine status is influenced by the adherence to therapy in early-treated adult PKU patients. However, thyroid function might not be affected in adult PKU.

Volume 56

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts